CGH
AVNS

Crossmark Global Holdings’s Avanos Medical AVNS Stock Holding History

Crossmark Global Holdings’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,380
Closed -$386K – 1380
2021
Q3 		$386K Buy
12,380
+70
+0.6% +$2.38K 0.01% 1052
2021
Q2 		$448K Buy
12,310
+10
+0.1% +$414 0.01% 984
2021
Q1 		$538K Sell
12,300
-20
-0.2% -$939 0.01% 865
2020
Q4 		$565K Buy
+12,320
New +$513K 0.01% 791
2019
Q4 		– Sell
-9,160
Closed -$343K – 1399
2019
Q3 		$343K Sell
9,160
-180
-2% -$6.87K 0.01% 980
2019
Q2 		$407K Sell
9,340
-521
-5% -$22.3K 0.01% 922
2019
Q1 		$421K Sell
9,861
-40
-0.4% -$1.79K 0.01% 915
2018
Q4 		$443K Buy
9,901
+5,470
+123% +$287K 0.01% 821
2018
Q3 		$304K Buy
4,431
+20
+0.5% +$1.29K 0.01% 1310
2018
Q2 		$253K Buy
4,411
+30
+0.7% +$1.58K 0.01% 1419
2018
Q1 		$202K Sell
4,381
-201
-4% -$9.54K 0.01% 1503
2017
Q4 		$212K Sell
4,582
-1,629
-26% -$74.9K 0.01% 1556
2017
Q3 		$280K Buy
+6,211
New +$265K 0.01% 1361
2016
Q3 		$280K Buy
+6,211
New +$218K 0.01% 1361

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Crossmark Global Holdings's AVNS Position: Q4 2021 in Review

Crossmark Global Holdings sold out of Avanos Medical (AVNS) in Q4 2021, closing a stake of 12,380 shares — an estimated $386K sold.

Crossmark Global Holdings first reported a position in AVNS in Q3 2016 and held it in 14 quarters. The position peaked at $565K in Q4 2020. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

  • Crossmark Global Holdings reported no remaining Avanos Medical position as of Q4 2021 after selling out during the quarter.
  • Crossmark Global Holdings sold 12,380 Avanos Medical shares in Q4 2021, an estimated $386K.
  • Crossmark Global Holdings first reported a position in Avanos Medical in Q3 2016 and held it in 14 quarters.
  • Crossmark Global Holdings's Avanos Medical position peaked at $565K in Q4 2020.
  • 297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on Crossmark Global Holdings's 13F filing for Q4 2021, filed 10 Jan 2022.